IJCM  Vol.7 No.12 , December 2016
Ocular Manifestations in Thyroid Eye Disorder: A Cross-Sectional Study from Nepal
Abstract: Background: Thyroid eye disease represents an organ-specific autoimmune process that is usually associated with thyroid disease. Graves’ disease is the most common thyroid abnormality associated with thyroid eye disease. Aim: This study was conducted for the profile of ocular manifestation in Thyroid Eye Disease (TED). Methodology: A cross-sectional study of 117 cases of thyroid dysfunction was carried out at BP Koirala Institute of Health System, out of which 84 (71.79%) cases had ocular manifestation. They were evaluated and analyzed in detail and the characteristics documented included patient’s demography, ocular and systemic history and as well as ocular examination and some of the systemic and laboratory findings. Results: In this study, mean age of presentation of TED was 39.7 years. 59 patients were female and 25 were male. The maximum patients of both sexes were in the fourth decade of their lives. The common lid signs were lid retraction and lid lag. Proptosis was seen in 33.3% of cases out of which 68% had bilateral proptosis. Corneal ulcer was seen in 7.1% and optic neuropathy in 1.2% of cases. In 27.3% of cases there was elevation of IOP. Dry eye was seen in 61.9% of cases and POAG seen in 8.3% of cases. In the study population 75% were hyperthyroiditic, 16.7% were hypothyroiditic and 8.3% were in euthyroid state. Conclusion: Female was more commonly affected. The maximum number of patients of both sexes was in the fourth decade of their lives. Hyperthyroidism patient had greater chance of ocular manifestation.
Cite this paper: Sabita, P. , Ajit, T. , Narayan, S. , Kumar, S. and Niranjan, A. (2016) Ocular Manifestations in Thyroid Eye Disorder: A Cross-Sectional Study from Nepal. International Journal of Clinical Medicine, 7, 814-823. doi: 10.4236/ijcm.2016.712088.

[1]   Hall, J. (2011) Guyton and Hall Textbook of Medical Physiology. 12th Edition, Saunders/Elsevier, Philadelphia, 907.

[2]   Boron, W.F. and Boulapep, E.L. (2012) Medical Physiology. 2nd Edition, Saunders, Philadelphia, 1052.

[3]   Tomer, Y. and Huber, A. (2009) The Etiology of Autoimmune Thyroid Disease: A Story of Genes and Environment. Journal of Autoimmunity, 32, 231-239.

[4]   Unnikrishnan, A.G., Kalra, S., Sahay, R.K., Bantwal, G., John, M. and Tewari, N. (2013) Prevalence of Hypothyroidism in Adults: An Epidemiological Study in Eight Cities of India. Indian Journal of Endocrinology and Metabolism, 17, 647-652.

[5]   Mahato, R.V., Jha, B., Singh, K.P., Yadav, B.K., Shah, S.K. and Lamsa, M. (2005) Status of Thyroid Disorders in Central Nepal: A Tertiary Care Hospital Based Study. International Journal of Applied Sciences and Biotechnology, 3, 119-122.

[6]   Maheshwari, R. and Weis, E. (2012) Thyroid Associated Orbitopathy. Indian Journal of Ophthalmology, 60, 87-93.

[7]   Population Pyramids of the World from 1950 to 2100.

[8]   Demographics of Nepal/Sex Ratio 2012.

[9]   Poudel, S. and Gurung, D.K. (2013) Prevalence of Smoking and Perceived Health Problems among Male Population of Dharan Municipality. Journal of Kathmandu Medical College, 2.

[10]   Graves’ Ophthalmopathy. From Wikipedia, the Free Encyclopedia.

[11]   Chua, J., Tham, Y.C., Liao, J., Zheng, Y., Aung, T., Wong, T.Y. and Cheng, C.Y. (2014) Ethnic Differences of Intraocular Pressure and Central Corneal Thickness: The Singapore Epidemiology of Eye Diseases Study. Ophthalmology, 121, 2013-2022.

[12]   Savini, G., Prabhawasat, P., Kojima, T., Grueterich, M. and Espana, E. (2008) The Challenge of Dry Eye Diagnosis. Clinical Ophthalmology, 2, 31-55.

[13]   Morganti, S., Ceda, G.P., Saccani, M., Milli, B., Ugolotti, D., Prampolini, R., Maggio, M., Valenti, G. and Ceresini, G. (2005) Thyroid Disease in the Elderly: Sex-Related Differences in Clinical Expression. Journal of Endocrinological Investigation, 28, 101-104.

[14]   Vanderpump, M.P.J., et al. (1995) The Incidence of Thyroid Disorders in the Community: A Twenty-Year Follow-Up of the Whickham Survey. Clinical Endocrinology (Oxford), 43, 55-68.

[15]   Li, H. and Li, J. (2015) Thyroid Disorders in Women. Minerva Medica, 106, 109-114.

[16]   Bartley, G.B., Fatourechi, V., Kadrmas, E.F., Jacobsen, S.J., Ilstrup, D.M., Garrity, J.A., et al. (1995) The Incidence of Graves’ Ophthalmopathy in Olmsted County, Minnesota. American Journal of Ophthalmology, 120, 511-517.

[17]   Woo, K.I., Kim, Y.-D. and Lee, S.Y. (2013) Prevalence and Risk Factors for Thyroid Eye Disease among Korean Dysthyroid Patients. Korean Journal of Ophthalmology, 27, 397-404.

[18]   Manji, N., Carr-Smith, J.D., Boelaert, K., Allahabadia, A., Armitage, M., Chatterjee, V. K., et al. (2006) Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype. The Journal of Clinical Endocrinology & Metabolism, 91, 4873-4880.

[19]   Kashkouli, M.B., Kaghazkanani, R., Heidari, I., Ketabi, N., Jam, S., Azarnia, S. and Pakdel, F. (2011) Bilateral versus Unilateral Thyroid Eye Disease. Indian Journal of Ophthalmology, 59, 363-366.

[20]   Bartley, G.B., Fatourechi, V., Kadrmas, E.F., Jacobsen, S.J., Ilstrup, D.M., Garrity, J.A., et al. (1996) The Chronology of Graves’ Ophthalmopathy in an Incidence Cohort. American Journal of Ophthalmology, 121, 426-434.

[21]   McDermott, M.T., Kidd, G.S., Dodson, L.E. and Hofeldt, F.D. (1986) Case Report: Hyperthyroidism Following Hypothyroidism. American Journal of the Medical Sciences, 291, 194-198.

[22]   Starrenburg, A.J., Cabezas, M., Gan, I.M., Njo, T.L., Rietveld, A.P. and Elte, J.W. (2010) Four Patients with Hypothyroid Graves’ Disease. Netherlands Journal of Medicine, 68, 178-180.

[23]   Ohnishi, T., Noguchi, S., Murakami, N., Nakahara, H., Hoshi, H., Jinnouchi, S., Futami, S., Nagamachi, S. and Watanabe, K. (1993) Levator Palpebrae Superioris Muscle: MR Evaluation of Enlargement as a Cause of Upper Eyelid Retraction in Graves Disease. Radiology, 188, 115-118.

[24]   Mourits, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A. and van der Gaag, R. (1989) Clinical Criteria for the Assessment of Disease Activity in Graves’ Ophthalmopathy: A Novel Approach. British Journal of Ophthalmology, 73, 639-644.

[25]   Saks, N.D., Burnstine, M.A. and Putterman, A.M. (2001) Glabellar Rhytids in Thyroid-Associated Orbitopathy. Ophthalmic Plastic & Reconstructive Surgery, 17, 91-95.

[26]   Asman, P. (2003) Ophthalmological Evaluation in Thyroid-Associated Ophthalmopathy. Acta Ophthalmologica Scandinavica, 81, 437-448.

[27]   King, J.S. and Netland, P.A. (2002) Glaucoma in Thyroid Eye Disease. In: Dutton, J.J. and Haik, B.G., Eds., Thyroid Eye Disease: Diagnosis and Treatment, CRC Press, Boca Raton, 319-325.

[28]   Cockerham, K.P., Pal, C., Jani, B., Wolter, A. and Kennerdell, J.S. (1997) The Prev-alence and Implications of Ocular Hypertension and Glaucoma in Thyroid-Associated Orbitopathy. Ophthalmology, 104, 914-917.

[29]   Gilbard, J.P. and Farris, R.L. (1983) Ocular Surface Drying and Tear Film Osmolarity in Thyroid Eye Disease. Acta Ophthalmologica, 61, 108-116.